Adherence to guidelines in idiopathic pulmonary fibrosis: A follow-up national survey

ERJ Open Research

Volumn 1, Issue 2, 2015, Pages

  Cottin, Vincent ^a   Bergot, Emmanuel ^b   Bourdin, Arnaud ^c   Cadranel, Jacques ^d   Camus, Philippe ^e   Crestani, Bruno ^f   Dalphin, Jean Charles ^g   Delaval, Philippe ^h   Dromer, Claire ⁱ   Israel Biet, Dominique ^j   Kessler, Romain ^k   Marchand Adam, Sylvain ^l   Marquette, Charles Hugo ^m   Prévot, Grégoire ⁿ   Reynaud Gaubert, Martine ^o   Valeyre, Dominique ^p   Wallaert, Benoit ^q   Bouquillon, Benoit ^r   Cordier, Jean François ^a  

^a UNIVERSITÉ LYON 1   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d HÔPITAL TENON   (France)

^e DIJON UNIVERSITY HOSPITAL   (France)

^f BICHAT HOSPITAL   (France)

^g UNIVERSITY HOSPITAL OF BESANÇON   (France)

^h RENNES UNIVERSITY HOSPITAL   (France)

ⁱ BORDEAUX UNIVERSITY HOSPITAL   (France)

^j HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^k UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^l UNIVERSITY HOSPITAL OF TOURS   (France)

^m UNIVERSITY HOSPITAL OF NICE   (France)

ⁿ TOULOUSE UNIVERSITY HOSPITAL   (France)

^o University Hospital   (France)

^p AVICENNE HOSPITAL   (France)

^q LILLE UNIVERSITY HOSPITAL   (France)

^r Opened Mind Health   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85017408812     PISSN: None     EISSN: 23120541     Source Type: Journal    
DOI: 10.1183/23120541.00032-2015     Document Type: Article

References (24)

1. Tomioka H, Imanaka K, Hashimoto K, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis-cross-sectional and longitudinal study. Intern Med 2007; 46: 1533-1542.
2. Mura M, Porretta MA, Bargagli E, et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study. Eur Respir J 2012; 40: 101-109.
3. Cottin V, Cadranel J, Crestani B, et al. Management of idiopathic pulmonary fibrosis in France: a survey of 1244 pulmonologists. Respir Med 2014; 108: 195-202.
4. Centre de Référence des Maladies Pulmonaires Rares, Centres de Compétences des Maladies Pulmonaires Rares. Discussion MultiDisciplinaire dans le cadre du diagnostic de la Fibrose Pulmonaire Idiopathique (FPI) [Multidisciplinary discussion within the framework of the diagnosis of idiopathic pulmonary fibrosis (IPF)]. http://splf.fr/wp-content/uploads/2014/08/206015-DIAGNOSTIC_FPI_CR-CC.pdf
5. Cottin V, Crestani B, Valeyre D, et al. Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique. Élaborées par le Centre national de référence et les centres de compétence pour les maladies pulmonaires rares sous l’égide de la Société de pneumologie de langue française. [French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. From the National Reference and the Competence centers for rare diseases and the Société de Pneumologie de Langue Française.] Rev Mal Respir 2013; 30: 879-902.
6. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
7. Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 2011; 377: 1760-1769.
8. Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2071-2082.
9. King TE Jr, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2083-2092.
10. Cordier JF, Cottin V. Neglected evidence in idiopathic pulmonary fibrosis: from history to earlier diagnosis. Eur Respir J 2013; 42: 916-923.
11. Doyle TJ, Hunninghake GM, Rosas IO. Subclinical interstitial lung disease: why you should care. Am J Respir Crit Care Med 2012; 185: 1147-1153.
12. Douglas WW, Ryu JH, Schroeder DR. Idiopathic pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survival. Am J Respir Crit Care Med 2000; 161: 1172-1178.
13. Nagai S, Kitaichi M, Hamada K, et al. Hospital-based historical cohort study of 234 histologically proven Japanese patients with IPF. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 209-214.
14. Gay SE, Kazerooni EA, Toews GB, et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 1998; 157: 1063-1072.
15. Winterbauer RH, Hammar SP, Hallman KO, et al. Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine. Am J Med 1978; 65: 661-672.
16. Raghu G, Depaso WJ, Cain K, et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis 1991; 144: 291-296.
17. Johnson MA, Kwan S, Snell NJ, et al. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 1989; 44: 280-288.
18. Collard HR, Ryu JH, Douglas WW, et al. Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. Chest 2004; 125: 2169-2174.
19. Pereira CA, Malheiros T, Coletta EM, et al. Survival in idiopathic pulmonary fibrosis-cytotoxic agents compared to corticosteroids. Respir Med 2006; 100: 340-347.
20. Cottin V. Current approaches to the diagnosis and treatment of idiopathic pulmonary fibrosis in Europe: the AIR survey. Eur Respir Rev 2014; 23: 225-230.
21. Wuyts WA, Peccatori FA, Russell AM. Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models. Eur Respir Rev 2014; 23: 231-238.
22. Troy LK, Chapman SA, Lake F, et al. Current Australasian practice for diagnosis and management of idiopathic pulmonary fibrosis: Where are we now? Respirology 2015; 20: 647-653.
23. Collard HR, Loyd JE, King TE Jr., et al. Current diagnosis and management of idiopathic pulmonary fibrosis: A survey of academic physicians. Respir Med 2007; 101: 2011-2016.
24. Raghu G, Rochwerg B, Zhang Y, et al. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med 2015; 192: e3-19.